664003, Russian Federation, Irkutsk, Timiryazeva st., 16
Version for the visually impaired иконка
EN RU

664003, Russian Federation, Irkutsk, Timiryazeva st., 16

EN RU
About Departments and Institutes Department heads Oleg B. Ogarkov

Oleg B. Ogarkov

Ogarkov OB

Doctor Oleg B. Ogarkov, PhD, MD, Dr.Sc., is a Director of Institute Epidemiology & Microbiology, Scientific Center for Family Health and Human Reproduction Problems (IEM), Irkutsk, Russia.

Scientific interests: molecular epidemiology; molecular microbiology; tuberculosis; HIV; viral hepatitis.

Doctor Oleg B. Ogarkov as a head researcher of IEM and PI a number international projects deal with studies the molecular epidemiology and microbiology of TB infection and treatment adherence in patients with TB and HIV. He also conducts extensive research on the genetics of viral hepatitis C with collaborators at Irkutsk Medical University.

Research support

  • 2023 to present time – PI of Federal R&D project # 121022500179-0 “Molecular, Organismal, and Population Patterns of Formation of the Epidemic Process of Anthroponoses and Transmissible Infections in Northern Asia and Adjacent Territories”
  • 2023 to present time – PI of RSF project # 23-15-00280 “An integrated molecular approach to the diagnostic of MDR/XDR tuberculosis with the development of an information and analytical system for personalized medicine and epidemic surveillance”)
  • 2020-2022 – PI of RFBR project 20-015-00078 А “Development of a unified molecular-biological approach for microbial communities monitoring in the lungs in infectious and non-infectious diseases (tuberculosis and lung cancer)”
  • 2017-2019 – PI of RFBR project “Individualized approaches to combat the HIV/drug-resistant TB epidemic in Irkutsk, Siberia”
  • 2016-2018 – NIH 2016 U01 AI Site PI “Diagnostics and Pharmacotherapy for Severe Forms of TB”
  • 2014-2015 – Site PI of NIH 2014 R21 AI “Genotyping and Pharmacokinetics in the HIV/MDR-TB epidemic of Eastern Siberia”
  • Doctor Oleg B. Ogarkov is a scientific supervisor of 3 Ph.D. students. He is co-author of a number of books devoted to epidemiology of tuberculosis and other social infections. He is a member of the editorial boards of journals: Pediatric Investigation (2096-3726) & Acta Biomedica Scientifica (2541-9420).

ORCID 0000-0002-3168-1983

Selected publications

  1. Zhdanova S, Jiao WW, Sinkov V, Khromova P, Solovieva N, Mushkin A, Mokrousov I, Belopolskaya O, Masharsky A, Vyazovaya A, Rychkova L, Kolesnikova L, Zhuravlev V, Shen AD, Ogarkov O. Insight into Population Structure and Drug Resistance of Pediatric Tuberculosis Strains from China and Russia Gained through Whole-Genome Sequencing. Int J Mol Sci. 2023 Jun 18;24(12):10302. doi: 10.3390/ijms241210302. WoS Q1
  2. Mokrousov I, Vyazovaya A, Shitikov E, Badleeva M, Belopolskaya O, Bespiatykh D, Gerasimova A, Ioannidis P, Jiao W, Khromova P, Masharsky A, Naizabayeva D, Papaventsis D, Pasechnik O, Perdigão J, Rastogi N, Shen A, Sinkov V, Skiba Y, Solovieva N, Tafaj S, Valcheva V, Kostyukova I, Zhdanova S, Zhuravlev V, Ogarkov O. Insight into pathogenomics and phylogeography of hypervirulent and highly-lethal Mycobacterium tuberculosis strain cluster. BMC Infect Dis. 2023 Jun 23;23(1):426. doi: 10.1186/s12879-023-08413-7. WoS Q2
  3. Sinkov VV, Kondratov IG, Ogarkov OB, Zhdanova SN, Sokolnikova NA, Khromova PA, Orlova EA, Rychkova LV, Kolesnikova LI. Online Service with Automated Interpretation of Sequencing Data and Prediction of Pyrazinamide Resistance in Mycobacterium tuberculosis. Bull Exp Biol Med. 2023 Mar;174(5):623-627. doi: 10.1007/s10517-023-05758-6. WoS Q3
  4. Ogarkov OB, Peretolchina NP, Malov SI, Orlova EA, Stepanenko LA, Khromova PA, Malov IV, Kolesnikov SI. A Method to Determine Xenobiotic Acetylation Rate by Taq SNP rs1495741. Bull Exp Biol Med. 2022 Aug;173(4):510-513. doi: 10.1007/s10517-022-05572-6. WoS Q3
  5. Galeeva, J., V. Babenko, P. Bashkirov... Ogarkov O [et al.] 16S rRNA gene sequencing data of the upper respiratory tract microbiome in the SARS-CoV-2 infected patients / // Data in Brief. – 2022. – Vol. 40. – P. 107770. – DOI 10.1016/j.dib.2021.107770. Scopus Q4
  6. Zhdanova S, Mokrousov I, Orlova E, Sinkov V, Ogarkov O. Transborder molecular analysis of drug-resistant tuberculosis in Mongolia and Eastern Siberia, Russia. Transbound Emerg Dis. 2022 Mar 16. doi: 10.1111/tbed.14515. Epub ahead of print. PMID: 35294112. WoS Q1
  7. Hodges J, Waldman AL, Koshkina O, Suzdalnitsky A, Schwendinger J, Vitko S, Plenskey A, Plotnikova Y, Moiseeva E, Koshcheyev M, Sebekin S, Zhdanova S, Ogarkov O, Heysell S, Dillingham R. Process evaluation for the adaptation, testing and dissemination of a mobile health platform to support people with HIV and tuberculosis in Irkutsk, Siberia. BMJ Open. 2022 Mar 29;12(3):e054867. doi: 10.1136/bmjopen-2021-054867. PMID: 35351714. Scopus Q1
  8. Vinogradova T, Dogonadze M, Zabolotnykh N, Badleeva M, Yarusova I, Vyazovaya A, Gerasimova A, Zhdanova S, Vitovskaya M, Solovieva N, Pasechnik O, Ogarkov O, Mokrousov I. Extremely lethal and hypervirulent Mycobacterium tuberculosis strain cluster emerging in Far East, Russia. Emerg Microbes Infect. 2021 Dec;10(1):1691-1701. doi: 10.1080/22221751.2021.1967704. PMID: 34380361; PMCID: PMC8381949. WoS Q1
  9. Hodges J, Zhdanova S, Koshkina O, Suzdalnitsky A, Waldman AL, Schwendinger J, Vitko S, Plenskey A, Plotnikova Y, Moiseeva E, Koshcheyev M, Sebekin S, Ogarkov O, Dillingham R, Heysell S. Implementation of a Mobile Health Strategy to Improve Linkage to and Engagement with HIV Care for People Living with HIV, Tuberculosis, and Substance Use in Irkutsk, Siberia. AIDS Patient Care STDS. 2021 Mar;35(3):84-91. doi: 10.1089/apc.2020.0233. Epub 2021 Feb 3. Scopus Q1
  10. Ogarkov O, P Khromova, V Sinkov, E Orlova, S Zhdanova, WW Jiao et al Metagenomic analysis of the lung tuberculomas microbiome: paucibacillary bacterial community International Journal of Mycobacteriology 2021. 10 (5), 13 DOI: 10.4103/2212-5531.307062 Scopus Q3
  11. Rao P, Zhdanova S, Ogarkov O, Orlova E, Ebers A, Stroup S, Mirawdaly S, Aartsen DV, Koshkina O, Suzdalnitsky A, Moiseeva E, Dillingham R, Heysell SK. Urine colorimetry for levofloxacin pharmacokinetics and personalized dosing in people with drug-resistant tuberculosis. Int J Mycobacteriol. 2020 Oct-Dec;9(4):411-416. WoS Q3 doi: 10.4103/ijmy.ijmy_186_20.
  12. Mokrousov I, Sinkov V, Vyazovaya A, Pasechnik O, Solovieva N, Khromova P, Zhuravlev V, Ogarkov O. Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia. Int J Antimicrob Agents. 2020 May 30:106036. doi: 10.1016/j.ijantimicag.2020.106036. WoS Q1
  13. Gray Neils ME, Pfaeffle HOI, Kulatti AT, Titova A, Lyles GS, Plotnikova Y, Zorkaltseva E, Ogarkov OB, Vitko SM, Dillingham RA, Heysell SK. A Geospatial Bibliometric Review of the HIV/AIDS Epidemic in the Russian Federation. Front Public Health. 2020 Apr 2;8:75. WoS Q2 doi: 10.3389/fpubh.2020.00075.
  14. Sinkov V.V., Ogarkov O.B., Plotnikov A.O., Gogoleva NE, Zhdanova SN, Pervanchuk VL, Belkova NL, Koshcheev ME, Thomas TA, Liu J, Zorkaltseva EY, Heysell SK. Metagenomic analysis of mycobacterial transrenal DNA in patients with HIV and tuberculosis coinfection. Infect. Genet. Evol. 2020. V. 77. С. 104057. doi: 10.1016/j.meegid.2019.104057. IF JCR 2018 - 2.611 Scopus Q1